The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Predictor of adverse pathology in patients who underwent deferred radical prostatectomy following active surveillance: Results from multi-institutional prospective observational cohort in the PRIAS-JAPAN.
 
Yoichiro Tohi
No Relationships to Disclose
 
Ryou Ishikawa
No Relationships to Disclose
 
Takuma Kato
No Relationships to Disclose
 
Jimpei Miyakawa
No Relationships to Disclose
 
Ryuji Matsumoto
No Relationships to Disclose
 
Keiichiro Mori
No Relationships to Disclose
 
Koji Mitsuzuka
No Relationships to Disclose
 
Junichi Inokuchi
No Relationships to Disclose
 
Masafumi Matsumura
No Relationships to Disclose
 
Kenichiro Shiga
No Relationships to Disclose
 
Hirohito Naito
No Relationships to Disclose
 
Yasuo Kohjimoto
No Relationships to Disclose
 
Norihiko Kawamura
No Relationships to Disclose
 
Masaharu Inoue
No Relationships to Disclose
 
Shusuke Akamatsu
No Relationships to Disclose
 
Naoki Terada
No Relationships to Disclose
 
Yoshiyuki Miyazawa
No Relationships to Disclose
 
Shintaro Narita
No Relationships to Disclose
 
Reiji Haba
No Relationships to Disclose
 
Mikio Sugimoto
Honoraria - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb Japan; Chugai Pharma; Janssen; Kissei Pharmaceutical; Nippon Shinyaku; Novartis; Pfizer; Takeda